secwatch.observer — SEC 8-K summary
======================================

Issuer:     APTARGROUP, INC. (ATR)
CIK:        0000896622
Form:       8-K
Filed at:   2021-07-30T23:59:59+00:00
Accession:  0001157523-21-000953
Event type: earnings
Sentiment:  neutral
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Aptar Q2 sales up 16% to $811M, adj EPS $0.91 (+7%), core sales +10%; Q3 guidance $0.90-$0.98
--------------------------------------------------------------------------------

- Reported sales $811M (+16% YoY); core sales +10% aided by double-digit growth in Beauty+Home and Food+Beverage.
- Reported EPS $0.81 (+29%); adj EPS $0.91 (+7% neutralizing currency); net income $55M (+32%).
- Pharma core sales +2% as destocking of allergic rhinitis/cough-cold inventory continues; elastomer demand strong.
- Free cash flow H1 $39M (down 63%) due to higher capex and working capital; cash from ops $176M (-23%).
- Q3 adj EPS guidance $0.90-$0.98; expects gradual improvement through H2 with acceleration toward year-end.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/896622/000115752321000953/0001157523-21-000953-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/896622/000115752321000953/a52468729.htm
  HTML page:      https://secwatch.observer/filing/0001157523-21-000953

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer